vTv Therapeutics Operating Expenses 2011-2026 | VTVT

Annual Operating Expenses vTv Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
24.6 M	25.7 M	18.3 M	23.7 M	32.3 M	51 M	55.7 M	38.7 M	30.4 M	36.8 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
55.7 M	18.3 M	33.7 M

Quarterly Operating Expenses vTv Therapeutics

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8 M	7.43 M	-	5.69 M	4.04 M	8.48 M	-	4.6 M	4.68 M	5.27 M	-	2.84 M	4.2 M	6.65 M	-	5.43 M	6.62 M	5.21 M	-	4.86 M	11.3 M	11.2 M	-	11.6 M	12.6 M	13.8 M	-	13.6 M	14.8 M	13.9 M	-	9.57 M	8 M	9.77 M	-	5.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14.8 M	2.84 M	8.15 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	216 M	$ 21.81	1.87 %	$ 1.02 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.91	1.61 %	$ 6.69 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.56	2.73 %	$ 3.74 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Esperion Therapeutics ESPR	343 M	$ 1.97	3.14 %	$ 409 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.43	4.29 %	$ 155 M	USA
Greenwich LifeSciences GLSI	16 M	$ 24.22	0.04 %	$ 315 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Heron Therapeutics HRTX	281 M	$ 1.21	1.26 %	$ 202 M	USA
ImmuCell Corporation ICCC	9.8 M	$ 8.22	-1.56 %	$ 74.2 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
InflaRx N.V. IFRX	52.4 M	$ 1.61	8.78 %	$ 152 M	Germany
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Innate Pharma S.A. IPHA	63 M	$ 1.4	-1.06 %	$ 235 M	France
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Inventiva S.A. IVA	36.2 M	$ 5.07	-1.65 %	$ 138 M	France
Jaguar Health JAGX	36 M	$ 0.34	-13.72 %	$ 793 K	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	512 M	$ 102.66	-2.66 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
KalVista Pharmaceuticals KALV	161 M	$ 19.68	0.25 %	$ 1.06 B	Britain
Aquestive Therapeutics AQST	85.5 M	$ 4.12	0.86 %	$ 441 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 23.45	0.82 %	$ 2.98 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	145 M	$ 1.44	-0.35 %	$ 383 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Ligand Pharmaceuticals Incorporated LGND	115 M	$ 232.91	0.71 %	$ 4.26 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Eli Lilly and Company LLY	11.8 B	$ 880.24	-0.42 %	$ 790 B	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.92	-0.34 %	$ 4.81 M	Israel
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA